openPR Logo

Press Releases from Kuick Resarch (873 total)

Global Antibody Drug Conjugate Market Sales Size Opportunity To Surpass US$ 10 B …

"Novel Cancer Antibody Drug Conjugates to Drive Cancer Therapeutics Market With More Than 290 Cancer Antibodies In Clinical Trials Pipeline Says Kuick Research" "Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Cancer Antibody Drug Conjugate (ADC) Pipeline: 297 Drugs • Marketed Cancer Antibody Drug Conjugate: 9 Drugs • Antibody Drug Conjugate Marketed Opportunity: > US$ 13 Billion By 2026 • Majority of Drug Trials Are For Second Line Therapy

Global Cell Therapy Market Stem Cell Therapy Market Size Sales Growth Clinical T …

Global Cell Therapy Market Size Sales Opportunity To Surpass USD 40 Billion By 2027 Says Kuick Research Report Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027 "Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights: • Global Cell Therapy Market: > USD 40 Billion By 2027 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Cell Therapy Price & Product Insight By Region/Country • Clinical

Global Small Molecule Targeted Cancer Drug Market Size Sales To Reach US$ 130 Bi …

"Global Small Molecule Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" Report Highlights: • Global Small Molecule Cancer Drug Market: > US$ 125 Billion by 2026 • USA Dominates Global Small Molecule Cancer Drug Market: >50% Share • Number of Small Molecule Cancer Drugs In Clinical Trials: >2500 Drugs • Small Molecule Cancer Drugs Dosage, Sales, Price & Patent Insight: 175 Drugs • Small Molecule Drug Insight by Cancer • Clinical Trials Insight

GCC Clinical Trial Market Outlook Insight 2025

"GCC Clinical Trial Market Outlook 2025" Report Highlights: • GCC Clinical Trial Market Opportunity: >US$ 500 Million • GCC Disease Prevalence & Statistics • Saudi Arabia Dominating GCC Clinical Trial Landscape: > 500 Trials • Clinical Trials for Cancer in GCC: > 120 Trials • Guidelines For Conducting Clinical Trials by Country • Ongoing Clinical Trials Insight by Country Download Report: https://www.kuickresearch.com/report-report-report-report-report-report-report-report-gcc-clinical-trial-market-size-number--data-regulation-registration Table of Contents 1. GCC Clinical Market Regional Insights 2. GCC Clinical Trial Market Dynamics 2.1 Driving Forces for GCC Clinical Trial

Saudi Arabia Diabetes Drug Device Market To Surpass US$ 2.5 Billion By 2025

"Saudi Arabia Diabetes Drug & Insulin Delivery Device Market Opportunity Outlook 2025" Report highlight: • Diabetes Drug Market Opportunity: > US$ 1.5 Billion by 2025 • Diabetes Device Market Opportunity: > US$ 1 Billion by 2025 • Glucose Monitoring Device Market Absolute Growth: 33% (2019-2025) • Oral Hypoglycemic Drugs Market - Availability, Dosage & Price Analysis • Insulin Availability, Dosage & Price Analysis • Insulin Delivery Device Market - Availability, Price & Sales Analysis • Glucose Monitoring Device Market - Availability & Price

Growing Opportunity with Saudi Arabia Diabetes Market

Among all the developed countries of Middle East, the country that is showing maximum trends and opportunities with respect to diabetes market is Saudi Arabia. With the urbanization and industrial development in the country, the population of Saudi Arabia has shown tremendous economic shift which has resulted in the influx of several kinds of diseases that were not observed in the country few years back. The momentum that the population

Cancer Tumor Organoid Modifying the Overall Cancer Market Scenario

Within no time, the organoid cultures for cancer treatment have emerged as one of the most powerful modeling system in the field of cancer biology. From the very beginning of the market, it has been experiencing high adoption rate among the researchers and patients, minimum side effects and maximum appreciation for being unique among all the other 2-D model systems available in the market. The arrival of cancer organoids by

Personalized Cancer Vaccine – A Novel Treatment for Poor Cancer Survival Rate

The ongoing clinical advancement that is represented by the personalized cancer vaccine is helping to identify the applications of vaccine across the multiple cancers. The development of novel cancer vaccines for the cancer treatment has transformed the overall and widespread adoption of the vaccines in the research community. An important factor that is promoting the growth of the vaccines in oncology research world is that it is shows significant potential

Small Molecule Cancer Drugs Drastically Improves the Cancer Survival

Small molecule drugs, which attack the cancer cells has been used to treat many different types of cancer with remarkable success every time. In the research field, the increase in the mortality of cancer has been majorly contributed by some of the treatment regimens that have an unwanted gesture against the cancer cells. The presence of non-specific cancer treatments such as chemotherapy or radiation therapy have made the study of

Bi-specific Antibodies For Enhanced Killing of the Foreign Cells Invaders

The availability of bi-specific antibodies has triggered a fundamental shift in the treatment paradigm for broad spectrum disease. The big pool of data available for the complex human system and its coupling with the advanced analytics tools have helped the researchers to come up with a treatment procedure that is unique and hold maximum promising outcomes for the huge percentage of patient population in the world. Bi-specific antibodies represent

Artificial Immune Modulation Therapy, An Upcoming Breakthrough in the Global Imm …

The platform provided by artificial immune modulation therapy comprises of a specific artificial matrix for the modulation of different antigen-presenting cells, which is an important part in the immune system. The methodology involved in the artificial immune modulation therapy represents simple yet powerful action against challenging mechanism of the cancer development and progression. The therapy involves engineering and administration of the artificial presenting cells to the patients so that

Exploitation of Immune Cells for Gaining Maximum Positive Outcomes in Cancer Mar …

The approach that has been focused by the cancer immunotherapies have helped in transforming the global cancer therapeutics market. Its arrival in the market has assisted the researchers to overcome all the challenges and short-imperative approach that has been delivered by the other commercially available cancer therapies. The fundamental principle of the immunotherapy which involves the cells of the immune cells holds great potential and huge difference in delivering promising

Global Cell Therapy Market To Surpass US$ 400 Billion In Opportunity By 2027 Wit …

"Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights: • Global Cell Therapy Market Opportunity: More Than USD 40 Billion By 2027 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Global Cell Therapy Clinical Pipeline: 1000 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Cell Therapy Trials For COVID-19: 10 Cell Therapies • Global COVID-19 Cell Therapy Clinical Trials By Phase & Company • COVID-19 Impact Analysis on Global market &

Global Cancer Immunotherapy Market Offers US$ 200 Billion Opportunity With 2300 …

"Global Cancer Immunotherapy Market Opportunity, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: • Global Cancer Immunotherapy Market Opportunity: > US$ 200 Billion • Cancer Immunotherapy Clinical Trials: > 2300 Drugs In Trials • Commercially Available Cancer Immunotherapies: > 120 • Cancer Vaccines Market Opportunity: > US$ 20 Billion • Cancer Monoclonal Antibodies Market Opportunity: > US$ 90 Billion • Marketed Cancer Monoclonal Antibodies': > 70 mAbs • Sales, Market Opportunity, Dosage & Price Data: 300 Graphs/Charts • Clinical Trials Insight By Phase,

Global Cell Therapy Market, Therapy Price, Dosage Clinical Trials 2027

"Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Highlights: • Global Cell Therapy Market Opportunity: More Than USD 40 Billion By 2027 • Cell Therapy Clinical Trial Insight by Indication, Company and Country • Global Cell Therapy Clinical Pipeline: 1000 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Cell Therapy Trials For COVID-19: 10 Cell Therapies • Global COVID-19 Cell Therapy Clinical Trials By Phase & Company • COVID-19 Impact Analysis on Global market &

Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027

"Global Cell Therapy Market, Therapy Price, Dosage & Clinical Trials Insight 2027" Report Insight: * Market Opportunity: >USD 40 Billion * Clinical Trial Insight: > 1000 Cell Therapies * COVID-19 Impact Analysis on Global Cell Therapy Market * Cell Therapies For COVID-19: > 10 Cell Therapies * Marketed Cell Therapies: 25 Cell Therapies Download Report: https://www.kuickresearch.com/report-global-cell-therapy-market,-therapy-price,-dosage-and-clinical-trials-insight-2027.php Table of Contents 1. Overview of Cell Therapy 1.1 Introduction to Cell Therapy 1.2 History & Evolution of

Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials In …

"Global Cancer Antibody Drug Conjugate Market, Price, Dosage & Clinical Trials Insight 2026" Report Highlights: o Global Cancer Antibody Drug Conjugate (ADC) Pipeline: 297 Drugs o Marketed Cancer Antibody Drug Conjugate: 9 Drugs o Antibody Drug Conjugate Marketed Opportunity: > US$ 13 Billion By 2026 o Majority of Drug Trials Are For Second Line Therapy Or Greater o USA Dominates Cancer ADC Clinical Trials Landscape: > 180 Drugs o Tubulin Modulators Dominates Cancer ADC Trials: > 60 Drugs o Sales, Market Opportunity, Clinical

Cancer Tumor Organoids Modelling Technology Market size Growth Assessment Person …

The research report "Global Cancer Tumor Organoids Modeling, Technology & Personalized Cancer Research Insight 2025" discusses about the recent trends and all the opportunities that the cancer organoid market have come across since the development of organoid technology in the research world. The research report delivers a comprehensive outlook about the transformation that the technique has brought in conducting cancer treatment as well as the transformation that the technique has

Global Transdermal Market Trends Demand Clinical Trials Pipeline Sales Opportuni …

The research report "Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" provides a comprehensive outlook about the wide applications that this delivery system in providing to the patients all over the globe. The research report also focuses towards introducing this delivery system and how it is contributing to relive the patients from the pain that the other drug delivery system provides in an elaborated way. In addition

Global Bispecific Antibodies Blincyto Hemlibra Market Sales Growth Clinical Tria …

The research report "Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026" provides a deep insight about the potential trends and the list of the drugs that are currently marketed under cancer bispecific antibodies. In addition to the general information, the research report also highlight the current scenario and various future prospects that the therapy is providing with respect to the growing cases of cancer at an

Cancer Immunotherapy Market Clinical Trials Pipeline Sales Growth opportunity In …

The research report ""Global Cancer Immunotherapy Market Opportunity, Dosage, Price & Clinical Trials Insight 2026" provides a deep insight about the recent trends and various opportunities that the therapy has brought to the cancer research world. In addition to the various trends that it has been following in the past few decades, the research report also discusses about the rise in the survival rate that the therapy has provided to

Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 202 …

"Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026" Report Highlights: o Global Bispecific Antibody Market Opportunity: > US$ 10 Billion o Global Bispecific Antibody Market Growth: 118% CAGR (2015 -2019) o Global Bispecific Antibody Market Growth In 2019: 280% (> US$ 1.5 Billion) o Global Bispecific Antibody Pipeline: 333 Drug o Commercially Available Bispecific Antibodies: 2 (Blincyto & Hemlibra) o Hemlibra Sales & Market Share 2019: > US$ 1.4 Billion & > 80%

Artificial Immune Modulation Therapy Market Opportunity & Clinical Trials Insigh …

"Artificial Immune Modulation Therapy Market Opportunity & Clinical Trials Insight 2026" Report Highlights: o Immunotherapy Inspired Design for Artificial Immune Modulation (AIM) o Artificial Immune Modulations for Various Indications o Clinical Trial Insight for AIM: 3 Drugs o Expected Price Range for AIM Therapy: > US$ 250,000 o Market Potential During Five Years of Commercialization: > USD 500 Million o Estimated Commercial Opportunity for Artificial Immune Modulation Drugs o Future Directions for Artificial Immune Modulation Download Report: https://www.kuickresearch.com/report-artificial-immune-modulation-therapy-market-opportunity-and-clinical-trials-insight-2026.php The research report "Artificial Immune

Global Cancer Photodynamic Therapy Market Size Clinical Trials Company Profile I …

The research report "Global Cancer Photodynamic Therapy Market & Clinical Trial Insight 2026" provides a comprehensive overview about the recent trends and opportunities that the market is following at a global level. The research report also discusses about the major key players and their varying strategies that have been employed in order to stay as a major contributor of the overall market. In addition to the information regarding major key

Global Cancer Generics Market Opportunity Valued At USD 55 Billion By 2026

"Global Cancer Generics Market, Drug Dosage, Price & Opportunity Insight 2026" Report Highlights: o Global Cancer Generics Market Trend Analysis o Global Cancer Generics Market Opportunity: > USD 55 Billion By 2026 o Global Generics Market Growth 2018-2026: > 130% o Global Cancer Generics Market Growth 2018-2026: 200% o Reimbursement Policies & the Coverage Strategies By Countries o Cancer Generic Drugs Availability, Dosage & Price Analysis By Segment o Comprehensive Insight On Cancer Generics Drugs: 43 Generics Download Report: https://www.kuickresearch.com/report-global-cancer-generics-market,-drug-dosage,-price-and-opportunity-insight-2026.php Table of Contents 1. Introduction to Cancer

Cancer Immunotherapy Has Emerged As Next Growth Frontier With US$ 200 Billion In …

"Global Cancer Immunotherapy Market Opportunity, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: o Global Cancer Immunotherapy Market Opportunity: > US$ 200 Billion o Cancer Immunotherapy Clinical Trials: > 2300 Drugs In Trials o Commercially Available Cancer Immunotherapies: > 120 o Cancer Vaccines Market Opportunity: > US$ 20 Billion o Cancer Monoclonal Antibodies Market Opportunity: > US$ 90 Billion o Marketed Cancer Monoclonal Antibodies': > 70 mAbs o Sales, Market Opportunity, Dosage & Price Data: 300 Graphs/Charts o Clinical Trials Insight By Phase,

Global Cancer Immunotherapy Market Opportunity, Dosage, Price and Clinical Trial …

"Global Cancer Immunotherapy Market Opportunity, Dosage, Price and Clinical Trials Insight 2026" Report Highlights: Global Cancer Immunotherapy Market Opportunity: > US$ 200 Billion Cancer Immunotherapy Clinical Trials: > 2300 Drugs In Trials Commercially Available Cancer Immunotherapies: > 120 Cancer Vaccines Market Opportunity: > US$ 20 Billion Cancer Monoclonal Antibodies Market Opportunity: > US$ 90 Billion Marketed Cancer Monoclonal Antibodies': > 70 mAbs Sales, Market Opportunity, Dosage and Price Data: 300 Graphs/Charts Clinical Trials Insight By Phase,

Global Cancer Generics Market, Drug Dosage, Price and Opportunity Insight 2026

"Global Cancer Generics Market, Drug Dosage, Price and Opportunity Insight 2026" Report Highlights: Global Cancer Generics Market Trend Analysis Global Cancer Generics Market Opportunity: > USD 55 Billion By 2026 Global Generics Market Growth 2018-2026: > 130% Global Cancer Generics Market Growth 2018-2026: 200% Reimbursement Policies and the Coverage Strategies By Countries Cancer Generic Drugs Availability, Dosage and Price Analysis By Segment Comprehensive Insight On Cancer Generics Drugs: 43 Generics Since the arrival of the generic

Global Cancer Photodynamic Therapy Market and Clinical Trial Insight 2026

"Global Cancer Photodynamic Therapy Market and Clinical Trial Insight 2026" Report Highlights: Global Cancer Photodynamic Therapy Market Opportunity: > US$ 4 Billion Share of Cancer in Photodynamic Therapy: > 40% US To Dominate Global Photodynamic Therapy Market Global Cancer Photosensitisers Clinical Pipeline: >10 Photosensitisers In Trials Marketed Cancer Photosensitisers: >5 US Dominating Global Clinical Trials Landscape: >10 Photosensitisers In Trials The research report "Global Cancer Photodynamic Therapy Market and Clinical Trial Insight 2026" to

Global Cancer Generics Drug Market Sales Opportunity At US$ 50 Billion

"Global Cancer Generics Market, Drug Dosage, Price & Opportunity Insight 2026" Report Highlights: o Global Cancer Generics Market Trend Analysis o Global Cancer Generics Market Opportunity: > USD 50 Billion o Reimbursement Policies & the Coverage Strategies By Countries o Cancer Generic Drugs Availability, Dosage & Price Analysis By Segment o Comprehensive Insight On Cancer Generics Drugs: 43 Generics Download Report: https://www.kuickresearch.com/report-global-cancer-generics-market,-drug-dosage,-price-and-opportunity-insight-2026.php Kuick Research Delhi,India,Tel; +91-11-47067990 Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business,

Global Personalized Cancer Vaccine Market Size Opportunity Trends Opportunity By …

"Global Personalized Cancer Vaccine Market, Clinical Trials & Future Outlook 2026" Report Highlights: o Personalized Cancer Vaccine Mechanism of Action o Biomarkers Importance In Personalized Vaccines o Ongoing Clinical Trials on Personalized Cancer Vaccine o Developmental Cost Analysis of a Personalized Cancer Vaccine o Immune Checkpoint Biomarkers Preventing Tumor Growth o Advancements in the Personalized Cancer Vaccine o Current Market Trends & Advancements in the Personalized Cancer Vaccine Segment This report on the personalized cancer vaccine market provides a comprehensive insight

Imports To Drive GCC Pharmaceutical Market Sales Size To USD 20 Billion By 2025

"GCC Pharmaceutical Market Opportunity Insight 2025" Report Highlights: o GCC Pharmaceutical Market Opportunity: > US$ 20 Billion o Patented & OTC Pharmaceutical Market Size: 75% of Total Market o Share of Imported Drugs In GCC Pharmaceutical Market: > 80% o Saudi Arabia Dominates GCC Pharmaceutical Market: 50% Market Share o GCC Pharmaceutical Clinical Trials Insight: > 700 Drugs Download Report: https://www.kuickresearch.com/report-gcc-pharmaceutical-market-opportunity-insight-2025.php The research report "GCC Pharmaceutical Market Opportunity Insight 2025" provides an in-depth analysis about the current market dynamics that includes

Hemlibra Sales To Drive Global Bispecific Antibody Market Drug Sales by 2026

"Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026" Report Highlights: o Global Bispecific Antibody Market Opportunity: > US$ 10 Billion o Global Bispecific Antibody Market Growth: 118% CAGR (2015 -2019) o Global Bispecific Antibody Market Growth In 2019: 280% (> US$ 1.5 Billion) o Global Bispecific Antibody Pipeline: 333 Drug o Commercially Available Bispecific Antibodies: 2 (Blincyto & Hemlibra) o Hemlibra Sales & Market Share 2019: > US$ 1.4 Billion & > 80%

Personalized Vaccine Transforming Oncology Cancer Market With USD 5 Billion Mark …

The approach of treating disease by the means of personalized vaccine has totally revolutionized and shifted the treatment regimen to a brand new chapter. The radical shifting of the treatment facilities and the modification of the expression of genes of specific individual made our team to conduct survey on the current market trends followed by the concept. The research report "xxx" represents market information regarding the subject and the detailed

Global Cancer Generics Market Size Sales Drug Dosage Price Insight 2026

The research report "Global Cancer Generics Market, Drug Dosage, Price & Opportunity Insight 2026" provides an in-depth analysis about the trends that are followed by the cancer generics market at the global and regional level as well as the revolutionizing strategies that have been adopted and supported by the governing and regulatory bodies around the globe. The research report is a result of the extensive study conducted by analyzing the

Immuno Oncology Market Size Sales Future Opportunity Clinical Trials Pipeline In …

Immuno-oncology refers to the ability of the immune cells to evade the cancer cells. It has been developed from the very basic idea of applying the power of immune cells to the current state-of-the-art in the case of various cancer types. The methodology is also used to manage the toxicities related to various cancer treatment methods. The research report "xxx" exploits the understanding about how immuno-oncology has been affecting the

Global Bispecific Antibody Market Size Sales Future Clinical Trials Pipeline Ins …

"Since Commercially Launch In 2015, The Global Bispecific Antibody Market Has Witnessed Growth of 118% CAGR Till 2019" "Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026" Report Highlights: o Global Bispecific Antibody Market Opportunity: > US$ 10 Billion o Global Bispecific Antibody Market Growth: 118% CAGR (2015 -2019) o Global Bispecific Antibody Market Growth In 2019: 280% (> US$ 1.5 Billion) o Global Bispecific Antibody Pipeline: 333 Drug o Commercially Available Bispecific

GCC Pharmaceutical Market Sales Size To Surpass USD 20 Billion By 2025

"GCC Pharmaceutical Market Opportunity Insight 2025" Report Highlights: o GCC Pharmaceutical Market Opportunity: > US$ 20 Billion o Patented & OTC Pharmaceutical Market Size: 75% of Total Market o Share of Imported Drugs In GCC Pharmaceutical Market: > 80% o Saudi Arabia Dominates GCC Pharmaceutical Market: 50% Market Share o GCC Pharmaceutical Clinical Trials Insight: > 700 Drugs Download Report: https://www.kuickresearch.com/report-gcc-pharmaceutical-market-opportunity-insight-2025.php The research report "GCC Pharmaceutical Market Opportunity Insight 2025" provides an in-depth analysis about the current market dynamics that includes

Global Cell Therapy Market size Sales Clinical Trials Pipeline Report 2026

"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: o Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 o Cell Therapy Clinical Trial Insight by Indication, Company & Country o Global Cell Therapy Clinical Pipeline: 767 Cell Therapies o Globally Marketed Cell Therapies: 25 Cell Therapies o Maximum Number of Marketed Cell Therapies In USA: 15 Therapies o Price & Product Insight By Region/Country o Regional Analysis of the Cell Therapy Market Download

Global Personalized Vaccine Market Offers USD 5 Billion Opportunity By 2026

Personalized vaccine is the result of the technological advancements that the current research and developmental sector are unraveling. Through the process of personalized vaccine, a treatment that is specific to the condition of the disease can be prepared and applied. It is achieved through the incorporation of other technologies such as genetics, clinical characteristics in treatment determination and molecular profiling. The arrival of such broad application technologies in the research

CRISPR Expanding the Gene Editing Technology Market

CRISPR is a major breakthrough considered in the field of biotechnology. The technology is capable of performing the actions that are lacking in the traditional genome editing technologies. The technology is capable of precisely altering the target DNA and carry out the required action. The technology of CRISPR is shorthand for CRISPR-Cas9. The unique function of Cas9 to perform as a molecular scissor is driving the performance rate of CRISPR

Cancer Organoids Revolutionizing Cancer Drug Research Development and Mapping th …

The technological advancements made in the field of cancer research have been driving the evolution in the way a research is conducted by the pharmaceutical scientists. The advent of cancer organoids in the medical world have been successful in moving the research cycle from in vivo cultures to in vitro cultures. The scope of the cultures prepared in vitro is not limited to the physiological aberrant environments as experienced in

Global Transdermal Patch Market To Surpass USD 18 Billion By 2026

Global Transdermal Patch Market To Surpass USD 18 Billion By 2026 Transdermal patches are widely accepted among physicians and patients due to their non-invasive, pain free and easy administration. In recent years, the growth of transdermal patch market has increased and expected to increase significantly in coming years. Higher investments in research and development could be attributed to the success of transdermal patch market. Number of disease indication treated by them

Global Bispecific Antibody Market Sales Size Increase 280% in 2019

Global Bispecific Antibody Market Sales Size Increase 280% in 2019 The sales of bispecific antibody products in 2019 rose by 280% in 2019 driven by 500% increase in sales of Hemlibra , as per recently published research report "Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026". "Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026" Report Highlights: o Global Bispecific Antibody Market Opportunity: >

GCC Pharmaceutical Market Sales Size Report 2025

GCC Pharmaceutical Market Sales Size Report 2025 According to "GCC Pharmaceutical Market Opportunity Insight 2025" Report, the pharmaceutical market opportunity in GCC is expected to surpass US$ 20 Billion by 2025. The GCC pharma market has been witnessing exponential growth driven by high demand of branded and patented drugs. "GCC Pharmaceutical Market Opportunity Insight 2025" Report Highlights: o GCC Pharmaceutical Market Opportunity: > US$ 20 Billion o Patented & OTC Pharmaceutical Market Size: 75%

Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insi …

"Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026" Report Highlights: o Global Bispecific Antibody Market Opportunity: > US$ 10 Billion o Global Bispecific Antibody Market Growth: 118% CAGR (2015 -2019) o Global Bispecific Antibody Market Growth In 2019: 280% (> US$ 1.5 Billion) o Global Bispecific Antibody Pipeline: 333 Drug o Commercially Available Bispecific Antibodies: 2 (Blincyto & Hemlibra) o Hemlibra Sales & Market Share 2019: > US$ 1.4 Billion & > 80%

Global Bispecific Antibody Market To Surpass USD 10 Billion By 2026

"Global Bispecific Antibody Market Opportunity, Drug Sales & Clinical Trials Insight 2026" Report Highlight: o Global Bispecific Antibody Market Opportunity: > US$ 10 Billion o Global Bispecific Antibody Market Growth: 118% CAGR (2015 -2019) o Global Bispecific Antibody Market Growth In 2019: 280% (> US$ 1.5 Billion) o Global Bispecific Antibody Pipeline: 333 Drug o Commercially Available Bispecific Antibodies: 2 (Blincyto & Hemlibra) o Hemlibra Sales & Market Share 2019: > US$ 1.4 Billion & >

Cancer Tumor Organoids To Transform Cancer Therapy Market With USD 400 Million O …

In cancer biology, an important aspect of developing a personalized anti-cancer therapy is by reconstructing the heterogeneity in the cancer models with respect to the specific patient. All along, the emergence of cancer organoids as an approach to create the cancer model derived from the patient with the unique property of resembling the pathophysiological features of the in-vivo tumor is however considered a breakthrough in the world where cancer cases

CRISPR Cas9 Gene Editing Market Presents USD 2 Billion Market Opportunity

The report "Global CRISPR Cas9 Market, Clinical Trials & Therapeutic Application Outlook 2024" specifies the breathless advances in the genetic engineering that became possible due to CRISPR technology. The report discusses the potential of the technology in different aspects, the major activities challenged by CRISPR and the current market trends that are followed by the technology. The report delivers the information about the parent markets of the technology. The report

Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026

"Global Transdermal Patch Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: • Global Transdermal Patch Market Opportunity: > US$ 15 Billion • Global Transdermal Patch Clinical Pipeline: 100 Patches In Trials • Clinical Insight on 66 Commercially/Marketed Transdermal Patches • Global Transdermal Patch Clinical Trials Insight by Company, Drug Class, Indication & Patent Information • Regional Trends & Market Insight: US, Europe & Asia-Pacific • Dosage & Price Insight on Transdermal Patch • Global Transdermal Patch Market Future Prospects Download Report:

Go To Page:   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18